NDC Package 0069-1309-04 Retacrit

Epoetin Alfa-epbx Injection, Solution Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-1309-04
Package Description:
4 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)
Product Code:
Proprietary Name:
Retacrit
Non-Proprietary Name:
Epoetin Alfa-epbx
Substance Name:
Epoetin
Usage Information:
This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). It may also be used in anemic patients to reduce the need for blood transfusions before certain planned surgeries that have a high risk of blood loss (usually given with an anticoagulant/"blood thinner" medication such as warfarin to lower the risk of serious blood clots). Epoetin alfa-epbx works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia.
11-Digit NDC Billing Format:
00069130904
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2047591 - epoetin alfa-epbx 10,000 UNT in 1 ML Injection
  • RxCUI: 2047591 - 1 ML epoetin alfa-epbx 10000 UNT/ML Injection
  • RxCUI: 2047591 - 1 ML EPO-epbx 10000 UNT/ML Injection
  • RxCUI: 2047591 - 1 ML ERYTHROPOIETIN-epbx 10000 UNT/ML Injection
  • RxCUI: 2047591 - epoetin alfa-epbx 10,000 UNT per 1 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA125545
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    06-18-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0069-1309-04 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00069130904Q5105Inj retacrit esrd on dialysi100 UNITS144001600
    00069130904Q5106Inj retacrit non-esrd use1000 UNITS1440160

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-1309-04?

    The NDC Packaged Code 0069-1309-04 is assigned to a package of 4 vial, single-dose in 1 carton / 1 ml in 1 vial, single-dose (0069-1309-01) of Retacrit, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is injection, solution and is administered via intravenous; subcutaneous form.

    Is NDC 0069-1309 included in the NDC Directory?

    Yes, Retacrit with product code 0069-1309 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on June 18, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0069-1309-04?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0069-1309-04?

    The 11-digit format is 00069130904. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-1309-045-4-200069-1309-04